PKCα acts as a tumor suppressor in intestinal epithelial cells via downregulation of cyclin D1, while PKCε appears to function as an oncogene in both transformed IEC-18 and colon cancer cells via positive regulation of cyclin D1 [52,53]. The gene discussed is PRKCE; the disease is colonic neoplasm.